-
Invitae Publishes its Environmental, Social and Governance (ESG) Report
-
Invitae Unveils New Research for Breast Cancer Patients with Variants of Uncertain Significance
-
Invitae Launches Update to Invitae Generation™: Clinical Variant Modeling Improves Variant Classification
-
Invitae Reports Estimated Unaudited Fourth Quarter and Full Year 2023 Financial Results
-
InVitae (NVTA) Files for Chapter 11
-
Invitae Files for Voluntary Chapter 11 Protection; Pursues Sale Process
-
InVitae (NVTA) Hires FTI, Kirkland & Ellis to Advise Options to Address $1.5 Billion of Debt - WSJ

